Last reviewed · How we verify

NCT05227599

BRAVE: Building Resilience and Values Through E-health

Completed NA Last updated 13 September 2023
What this trial tests

NA trial testing Online survey questionnaire in Survivorship in 56 participants. Completed in 24 March 2022.

Timeline
1 March 2021
Primary endpoint
24 March 2022
24 March 2022

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment56
Start date1 March 2021
Primary completion24 March 2022
Estimated completion24 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

Adults 11 to 25, any sex, with Survivorship. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the feasibility and acceptability of tracking survivors' and their caregivers, stressors, affect, and symptoms using an electronic diary method, in the time period surrounding their routine check- up with their oncologist.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Online survey questionnaire

Trials testing the same drug.

Other recruiting trials for Survivorship

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05227599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing